GS1-144 tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GS1-144 tablets, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women. [Phase 2]